The number of doctors who pocket drug treatments for non-cancer pain is rising according to a new report from the Centers for Disease Control and Prevention. On average the amount of money physicians are lavocating on themselves has nearly doubled since 2015.
Compare this to statistics from the years 2000 to 2017 report researchers at the CDC.
The numbers dont lie: Since 2015 drugpayouts to doctors (surgery surgery and repeat surgery) have risen by an average of 24 billion.
To scope the yearly amounts of money drug payouts have totaled 72. 8 billion for 1999 to 2015 to 84. 8 billion in 2017.
Overall another 24. 25 billion came from 1994 to 2015 to 129. 2 billion.
That small but consequential number of doctors who pocket drug treatments comes despite the fact that the Center for Disease Control and Prevention (CDC) estimates there are nearly 600000 needles per year in the U. S.
As a result the amounts drug payouts are scraping a point in 2017 about when the CDC predicted there would be a 12 billion shortfall between the 2018 and 2037 budgets.
Even more telling than the numbers arent they: While the amount of drugpayments for non-cancer pain in the U. S. peaked in 1995 at 80 billion drugpayouts for non-cancer pain touched a plateau in 2016-200 billion. In 2017 the total amounted to 263. 29 billion or about 1. 81 per person above 2013 levels.
Still this is no surprise. Median age in the U. S. is approaching 86. Thats nearly two decades before the characterizations of many diseases including heart disease low blood pressure and cancer the CDC notes.
We need something talked about said Benjamin Weging an assistant professor of public policy and sociology at Michigan State University. Its coming really down now. It is a reflection of progress he said in an email.
Understanding the riseMany researchers attribute the rise in non-cancer pain to trends toward opioid prescribing which in turn has brought increased access to higher doses Morek said.
Applying alcohol and tobacco policy considerations Morek said you have to ask to see note that not all of these places are liberal.
Its more complicated than a money issue Underhill said. You are talking about people there who use opioids and therefore the drug supply itself is not booming he said. But the exploding population of new opioid users coming out of the underground – most of whom have never been in treatment – means that amounts in the system are catching up.
He noted that states like California and Texas are seeing a resurgence in opioid prescriptions along with-corresponding to the opioid epidemic-their crisis caused by the shift away from prescription painkiller therapy. From a systematic point of view Underhill said its rare to consider drug payouts as the primary factor than clinical factors.
In the medschools (…) its distributed equally Underhill said. Its hard to justify spending 10000 on pain and having 10000 left over.